Assessment of risk of bias is regarded as an essential component of a systematic review on
the effects of an intervention. The most commonly used tool for randomised trials is the …

Background Several countries affected by the COVID-19 pandemic have reported a
substantial drop in the number of patients attending the emergency department with acute …

Objective To assess the effects of selective cyclo-oxygenase-2 (COX 2) inhibitors and
traditional non-steroidal anti-inflammatory drugs (NSAIDs) on the risk of vascular events …

Epidemiological studies of middle-aged populations generally find the relationship between
alcohol intake and the risk of coronary heart disease (CHD) and stroke to be either U-or J …

Context The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation more
accurately estimates glomerular filtration rate (GFR) than the Modification of Diet in Renal …

Background Large trials have shown that sodium glucose co-transporter-2 (SGLT2)
inhibitors reduce the risk of adverse kidney and cardiovascular outcomes in patients with …

Background REGEN-COV is a combination of 2 monoclonal antibodies (casirivimab and
imdevimab) that bind to two different sites on the receptor binding domain of the SARS-CoV …

INTRODUCTION Obesity accounts for a substantial and growing burden of disease globally.
Body adiposity is highly heritable, and human genetic studies can lead to biological and …

Task Force structure and summary of clinical evidence of 2022 ESC/EACTS review of the
2018 guideline recommendations on the revascularization of left main coronary artery …

Objective To examine the associations between a biomarker of overall passive exposure to
tobacco smoke (serum cotinine concentration) and risk of coronary heart disease and stroke …